This case illustrates that TPO cfRNA can be a potential tool to detect recurrent or persistent thyroid cancer, and its level can fall within a day after treatment, indicating that measurements are instant snapshots of the molecular physiology in time. This evidence concerns the gene TPO and thyroid cancer.